Literature DB >> 7085901

Clostridium difficile and cytotoxin in routine faecal specimens.

J Q Nash, B Chattopadhyay, J Honeycombe, S Tabaqchali.   

Abstract

Over a five-month period 1239 unselected, routine faecal specimens from 856 patients were examined for Clostridium difficile. One hundred specimens representing 69 patients were culture-positive. Toxin was detected in the stool of ten. During the study period, there were 41 Salmonella, 12 Campylobacter and 9 Shigella infections. C difficile was isolated together with Salmonella from 12 patients. No patient required specific treatment for C difficile infection. The significance of these findings is discussed.

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 7085901      PMCID： PMC497718          DOI： 10.1136/jcp.35.5.561

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN： 0021-9746            Impact factor:   3.411


  18 in total

1.  Identification of Clostridium difficile as a cause of pseudomembranous colitis.

Authors:  R H George; J M Symonds; F Dimock; J D Brown; Y Arabi; N Shinagawa; M R Keighley; J Alexander-Williams; D W Burdon
Journal:  Br Med J       Date:  1978-03-18

2.  Undescribed toxin in pseudomembranous colitis.

Authors:  H E Larson; J V Parry; A B Price; D R Davies; J Dolby; D A Tyrrell
Journal:  Br Med J       Date:  1977-05-14

3.  Antibiotic-associated pseudomembranous colitis due to toxin-producing clostridia.

Authors:  J G Bartlett; T W Chang; M Gurwith; S L Gorbach; A B Onderdonk
Journal:  N Engl J Med       Date:  1978-03-09       Impact factor: 91.245

4.  Randomised controlled trial of vancomycin for pseudomembranous colitis and postoperative diarrhoea.

Authors:  M R Keighley; D W Burdon; Y Arabi; J A Williams; H Thompson; D Youngs; M Johnson; S Bentley; R H George; G A Mogg
Journal:  Br Med J       Date:  1978-12-16

5.  Selective and differential medium for isolation of Clostridium difficile.

Authors:  W L George; V L Sutter; D Citron; S M Finegold
Journal:  J Clin Microbiol       Date:  1979-02       Impact factor: 5.948

6.  Cultures for Clostridium difficile in stools containing a cytotoxin neutralized by Clostridium sordellii antitoxin.

Authors:  S H Willey; J G Bartlett
Journal:  J Clin Microbiol       Date:  1979-12       Impact factor: 5.948

7.  Aetiology of antimicrobial-agent-associated colitis.

Authors:  W L George; V L Sutter; E J Goldstein; S L Ludwig; S M Finegold
Journal:  Lancet       Date:  1978-04-15       Impact factor: 79.321

8.  Pseudomembranous colitis: Presence of clostridial toxin.

Authors:  H E Larson; A B Price
Journal:  Lancet       Date:  1977 Dec 24-31       Impact factor: 79.321

9.  Clostridium difficile and the aetiology of pseudomembranous colitis.

Authors:  H E Larson; A B Price; P Honour; S P Borriello
Journal:  Lancet       Date:  1978-05-20       Impact factor: 79.321

10.  Therapeutic implications of Clostridium difficile toxin during relapse of chronic inflammatory bowel disease.

Authors:  J T LaMont; Y M Trnka
Journal:  Lancet       Date:  1980-02-23       Impact factor: 79.321
View more
  10 in total

1.  Molecular studies on the epidemiology and pathogenicity of Clostridium difficile.

Authors:  S Tabaqchali
Journal:  Gut       Date:  1989-11       Impact factor: 23.059

2.  A selective enrichment broth for the isolation of Clostridium difficile.

Authors:  S O'Farrell; M Wilks; J Q Nash; S Tabaqchali
Journal:  J Clin Pathol       Date:  1984-01       Impact factor: 3.411

3.  Cell surface binding site for Clostridium difficile enterotoxin: evidence for a glycoconjugate containing the sequence Gal alpha 1-3Gal beta 1-4GlcNAc.

Authors:  H C Krivan; G F Clark; D F Smith; T D Wilkins
Journal:  Infect Immun       Date:  1986-09       Impact factor: 3.441

4.  Intestinal colonization of infant hamsters with Clostridium difficile.

Authors:  R D Rolfe; J P Iaconis
Journal:  Infect Immun       Date:  1983-11       Impact factor: 3.441

5.  Binding kinetics of Clostridium difficile toxins A and B to intestinal brush border membranes from infant and adult hamsters.

Authors:  R D Rolfe
Journal:  Infect Immun       Date:  1991-04       Impact factor: 3.441

Review 6.  Clostridium difficile: clinical disease and diagnosis.

Authors:  F C Knoop; M Owens; I C Crocker
Journal:  Clin Microbiol Rev       Date:  1993-07       Impact factor: 26.132

7.  Asymptomatic neonatal colonisation by Clostridium difficile.

Authors:  R P Bolton; S K Tait; P R Dear; M S Losowsky
Journal:  Arch Dis Child       Date:  1984-05       Impact factor: 3.791

8.  Nosocomial diarrhoeas in a surgical division hyperendemic for Clostridium difficile: epidemiologic aspects emerging from an analysis of clinical records.

Authors:  P Urbano; S Le Brun
Journal:  Eur J Epidemiol       Date:  1986-12       Impact factor: 8.082

9.  Clinical significance of Clostridium difficile and its toxins in faeces of immunocompromised children.

Authors:  M J Wolfhagen; K Meijer; A C Fluit; R Torensma; R A Bruinsma; A Fleer; J Verhoef
Journal:  Gut       Date:  1994-11       Impact factor: 23.059

Review 10.  The role of Clostridium difficile in the paediatric and neonatal gut - a narrative review.

Authors:  E A Lees; F Miyajima; M Pirmohamed; E D Carrol
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-04-23       Impact factor: 3.267
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.